Birdwatch Note
2023-04-08 14:06:14 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The suspension of the drug is due to safety concerns. "The Court does not second-guess FDA’s decision-making lightly," Kacsmaryk wrote. "But here, FDA acquiesced on its legitimate safety concerns” https://www.nbcnews.com/news/us-news/abortion-pill-case-texas-judge-halts-access-mifepristone-rcna72117
Written by 315046F152AF8280D54473F7FBD31897AC05369971A0BE954A1E55C32CF81785
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1644491893169070080
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1644703200526626818
- noteId - 1644703200526626818
- participantId -
- noteAuthorParticipantId - 315046F152AF8280D54473F7FBD31897AC05369971A0BE954A1E55C32CF81785 Participant Details
- createdAtMillis - 1680962774770
- tweetId - 1644491893169070080
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The suspension of the drug is due to safety concerns. "The Court does not second-guess FDA’s decision-making lightly," Kacsmaryk wrote. "But here, FDA acquiesced on its legitimate safety concerns” https://www.nbcnews.com/news/us-news/abortion-pill-case-texas-judge-halts-access-mifepristone-rcna72117
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-04-08 14:06:14 UTC (1680962774770) |
1969-12-31 23:59:59 UTC (-1) |
2023-04-09 03:11:46 UTC (1681009906215) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-04-08 12:30:57 -0500 | Rating Details | |
2023-04-08 12:29:14 -0500 | Rating Details | |
2023-04-08 12:15:26 -0500 | Rating Details | |
2023-04-08 11:51:19 -0500 | Rating Details | |
2023-04-08 11:19:56 -0500 | Rating Details | |
2023-04-08 11:05:48 -0500 | Rating Details | |
2023-04-08 09:52:22 -0500 | Rating Details | |
2023-04-08 09:13:42 -0500 | Rating Details | |
2023-04-09 17:18:18 -0500 | Rating Details | |
2023-04-09 17:09:04 -0500 | Rating Details | |
2023-04-09 09:21:21 -0500 | Rating Details | |
2023-04-12 01:19:06 -0500 | Rating Details | |
2023-04-12 00:59:02 -0500 | Rating Details | |
2023-04-11 23:12:30 -0500 | Rating Details | |
2023-04-11 21:24:35 -0500 | Rating Details | |
2023-04-11 20:56:52 -0500 | Rating Details | |
2023-04-26 10:31:27 -0500 | Rating Details | |
2023-04-09 17:18:18 -0500 | Rating Details | |
2023-04-08 11:05:48 -0500 | Rating Details | |
2023-04-12 00:59:02 -0500 | Rating Details | |
2023-04-08 12:30:57 -0500 | Rating Details | |
2023-04-08 11:51:19 -0500 | Rating Details | |
2023-04-12 01:19:06 -0500 | Rating Details | |
2023-04-08 09:52:22 -0500 | Rating Details | |
2023-04-09 09:21:21 -0500 | Rating Details | |
2023-04-08 12:15:26 -0500 | Rating Details | |
2023-04-26 10:31:27 -0500 | Rating Details | |
2023-04-09 17:09:04 -0500 | Rating Details | |
2023-04-11 20:56:52 -0500 | Rating Details | |
2023-04-08 09:13:42 -0500 | Rating Details | |
2023-04-08 12:29:14 -0500 | Rating Details | |
2023-04-11 21:24:35 -0500 | Rating Details | |
2023-04-11 23:12:30 -0500 | Rating Details | |
2023-04-08 11:19:56 -0500 | Rating Details |